Perrigo is exploring new markets with a 'disruptive growth' team, focusing on women's health and GLP-1 side effect relief.

Shares of Perrigo Co. PLC PRGO slipped 1.43% to $24.79 Tuesday, on what proved to be an all-around great trading session for ...

Perrigo Co. PLC closed 24.93% short of its 52-week high of $33.50, which the company achieved on January 29th.

Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, February 05 based on AAII’s Stock Grades.

Perrigo Co plc (NYSE:PRGO), a global provider of pharmaceutical preparations with annual revenue of $4.39 billion and a market capitalization of $3.42 billion, announced today that Katherine Doyle, an ...

The new poll shows that 87% of Brits would back a law requiring AI developers to prove their systems are safe before release, ...

Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed.

Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer ...

White Falcon Capital Management, an investment fund manager, released its fourth-quarter 2024 investor letter. A copy of the ...

The Vatican and the U.S. Conference of Catholic Bishops have warned for years that emergency contraceptives could induce ...

Opill®— the first and only daily birth control pill available without a prescription in the U.S. —launched an educational ...